# Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection

> **NCT00700375** · PHASE4 · COMPLETED · sponsor: **Osaka General Medical Center** · enrollment: 59 (actual)

## Conditions studied

- Emergent Coronary Procedure

## Interventions

- **DRUG:** Sodium bicarbonate
- **DRUG:** Sodium Chloride

## Key facts

- **NCT ID:** NCT00700375
- **Lead sponsor:** Osaka General Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2010-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00700375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00700375, "Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00700375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*